How to Treat Cisplatin-Ineligible Metastatic Bladder Cancer: CPi Strategies w/Atezolizumab and Pembrolizumab
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Aziz Karaoglu
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Aziz Karaoglu
Comments 0
Login to view comments.
Click here to Login